Acute lower limb ischemia in a patient with aortic thrombus and essential thrombocytosis
Tóm tắt
Aortic thrombus is rare in patients with essential thrombocytosis (ET), so the optimal treatment remains undefined. A 45-year-old man with history of ET, under chronic treatment with aspirin, presented to the emergency department complaining of acute onset in both the legs and abdominal pain. Physical examination revealed that both dorsalis pedis pulses were not palpable with cold and pale feet. His abdomen was soft and nondistended. The platelet count was 436 × 109/L. The thoraco-abdominal computerized tomographic scanning revealed normal aortic diameter with supraceliac and infrarenal nonoccluding thrombus and infarction areas in spleen and left kidney. At the emergency department he presented with recurrent symptoms, losing bilateral posterior tibial pulses. A decision was made to perform a thoracoretroperitoneal incision. A longitudinal sequential aortotomy was performed in the distal thoracic and infrarenal aorta, and the thrombus was easily removed. Following this, he underwent bilateral crural thrombectomy and local intra-arterial thrombolytic therapy. The postoperative course was uneventful. The left toes were amputated because of necrosis. He was discharged and put on antiaggregants, anticoagulants and hydroxyurea. Aortic thrombus in patients with ET is unusual, but potentially lethal. There is complete relief from symptoms in recurrent cases following surgery. An appropriate medical treatment after intervention must be supported.
Tài liệu tham khảo
Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from and ad hoc international expert panel. Blood. 2007;110:1092–7.
van Genderen PJ, Michiels JJ. Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann Hematol. 1993;67:57–62.
van Genderen PJ, Lucas IS, van Strik R, Vuzevski VD, Prins FJ, van Vliet HH, et al. Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation. Thromb Haemost. 1996;76:333–8.
Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med. 1995;332:1132–6.
Ahmed S, Sadiq A, Siddiqui AK, Borgen E, Mattana J. Paradoxical arterial emboli causing acute limb ischemia in a patient with essential thrombocytosis. Am J Med Sci. 2003;326:156–8.
Chebli JM, Gaburri PD, Meirelles de Souza AF, Gonçalves Felga GE, Forn CG, Ferreira Pinto JR. Splenic-portal-mesenteric thrombosis with splenic infarction as first presentation of essential thrombocytosis. J Clin Gastroenterol. 2004;38:540–1.
Johnson M, Gernsheimer T, Johansen K. Essential thrombocytosis: underemphasized cause of large-vessel thrombosis. J Vasc Surg. 1995;22:443–7.
Lorelli DR, Shepard AD. Aortic mural thrombus embolization: an unusual presentation of essential thrombocytosis. Ann Vasc Surg. 2002;16:375–9.
Fang M, Agha S, Lockridge L, Lee R, Cleary JP, Mazur EM. Medical management of a large aortic thrombus in a young woman with essential thrombocythemia. Mayo Clin Proc. 2001;76:427–31.
Michiels JJ, De Raeve H, Berneman Z, Van Bockstaele D, Hebeda K, Lam K, et al. The 2001 World Health Organization (WHO) and updated European clinical and pathological (ECP) criteria for the diagnosis, classification and staging of the Ph1-chromosome negative chronic myeloproliferative disorders (MPD). Sem Thromb Hemostas. 2006;32:307–40.
Carobbio A, Finazzi G, Guerini V, Spinelli O, Delaini F, Marchioli R, et al. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: Interaction with treatment, standard risk factors, and Jak2 mutation status. Blood. 2007;109:2310–3.
Carobbio A, Finazzi G, Antonioli E, Guglielmelli P, Vannucchi AM, Delaini F, et al. Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia. Blood. 2008;112:3135–7.
Lozano P, Gomez FT, Julia J, M-Riambau E, García F. Recurrent embolism caused by floating thrombus in the thoracic aorta. Ann Vasc Surg. 1998;12:609–11.
Choukroun EM, Labrousse EM, Madonna FP, Deville C. Mobile thrombus of the thoracic aorta: diagnosis and treatment in 9 cases. Ann Vasc Surg. 2002;16:714–22.
Choi JB, Choi SH, Kim NH, Jeong JW. Floating thrombus in the proximal aortic arch. Tex Heart Inst J. 2004;31:432–4.
Böckler D, von Tengg-Kobligk H, Schoebinger M, Gross ML, Schumacher H, Ockert S, et al. An unusual cause of peripheral artery embolism: floating thrombus of the thoracic aorta surgically removed. Vasa. 2007;36:121–3.
Fueglistaler P, Wolff T, Guerke L, Stierli P, Eugster T. Endovascular stent graft for symptomatic mobile thrombus of the thoracic aorta. J Vasc Surg. 2005;42:781–3.
Luebke T, Aleksic M, Brunkwall J. Endovascular therapy of a symptomatic mobile thrombus of the thoracic aorta. Eur J Vasc Endovasc Surg. 2008;36:550–2.
Loscalzo J. Resolution of platelet-rich thrombi in essential thrombocythemia: mechanisms, risks, and benefits of antiplatelet therapy. Mayo Clin Proc. 2001;76:356–7.
Sohn V, Arthurs Z, Andersen C, Starnes B. Aortic thrombus due to essential thrombocytosis: strategies for medical and surgical management. Ann Vasc Surg. 2008;22:676–80.